Evaluation of Apaf-1 and procaspases-2, -3, -7, -8, and -9 as potential prognostic markers in acute leukemia

Svingen, P. A., Karp, J. E., Krajewski, S., Mesner, P. W., Gore, S. D., Burke, P. J., Reed, J. C., Lazebnik, Y. A., Kaufmann, S. H. (2000) Evaluation of Apaf-1 and procaspases-2, -3, -7, -8, and -9 as potential prognostic markers in acute leukemia. Blood, 96 (12). pp. 3922-3931. ISSN 0006-4971

URL: http://www.ncbi.nlm.nih.gov/pubmed/11090079

Abstract

Recent studies have suggested that variations in levels of caspases, a family of intracellular cysteine proteases, can profoundly affect the ability of cells to undergo apoptosis. In this study, immunoblotting was used to examine levels of apoptotic protease activating factor-1 (Apaf-1) and procaspases-2, -3, -7, -8, and -9 in bone marrow samples (at least 80% leukemia) harvested before chemotherapy from adults with newly diagnosed acute myelogenous leukemia (AML, 42 patients) and acute lymphocytic leukemia (ALL, 18 patients). Levels of each of these polypeptides varied over a more than 10-fold range between specimens. In AML samples, expression of procaspase-2 correlated with levels of Apaf-1 (R(s) = 0.52, P <.02), procaspase-3 (R(s) = 0.56, P <.006) and procaspase-8 (R(s) = 0.64, P <.002). In ALL samples, expression of procaspases-7 and -9 was highly correlated (R(s) = 0.90, P <.003). Levels of these polypeptides did not correlate with prognostic factors or response to induction chemotherapy. In further studies, 16 paired samples (13 AML, 3 ALL), the first harvested before induction therapy and the second harvested at the time of leukemia regrowth, were also examined. There were no systematic alterations in levels of Apaf-1 or procaspases at relapse compared with diagnosis. These results indicate that levels of initiator caspases vary widely among different leukemia specimens but cast doubt on the hypothesis that this variation is a major determinant of drug sensitivity for acute leukemia in the clinical setting. (Blood. 2000;96:3922-3931)

Item Type: Paper
Uncontrolled Keywords: Acute Disease Adolescent Adult Aged Antineoplastic Combined Chemotherapy Protocols Apoptotic Protease-Activating Factor 1 Bone Marrow Cells Caspases Cohort Studies Enzyme Precursors HL-60 Cells Humans Immunoblotting Leukemia Leukemia, Myeloid Middle Aged Precursor Cell Lymphoblastic Leukemia-Lymphoma Prognosis Proteins Tumor Markers, Biological
Subjects: diseases & disorders > cancer
organs, tissues, organelles, cell types and functions > cell types and functions > cell functions > apoptosis
diseases & disorders > cancer > cancer types > leukemia
CSHL Authors:
Communities: CSHL labs > Labeznik lab
Depositing User: Matt Covey
Date: 2000
Date Deposited: 12 Dec 2012 17:31
Last Modified: 12 Dec 2012 17:31
Related URLs:
URI: http://repository.cshl.edu/id/eprint/26388

Actions (login required)

Administrator's edit/view item Administrator's edit/view item
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving